In conclusion, the above results suggest that GPR50 can improve inflammation and regulate insulin resistance through the regulation of the insulin signaling pathway, which may be accomplished by targeting PPAR‐γ transcription. The gene discussed is GPR50; the disease is Insulin resistance.